Opioid Induced Constipation Treatment Market Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028
Opioid Induced Constipation Treatment Market
Opioids are a group of drugs that
are frequently recommended for their ability to lessen or even eliminate pain
in cases of chronic, non-cancerous pain. The fact that these drugs slow down
the gastrointestinal tract's motility, causing solid discharges and aggravating
patients, is a common side effect associated with their use. Additionally,
long-term opioid use can harm the sensory system, which prevents body cells
from producing endogenous opioids like endorphins. Adults are at a higher risk
of constipation due to poor diet, inadequate fluid intake, and inactivity.
One of the main factors
propelling growth of the opioid
induced constipation (OIC) treatment market is the increase in patients
using illegal drugs and the postponed use of opioids in the treatment of
chronic pain. Additionally, it has been noted that the untapped market for
beneficial, effective, and safe therapeutic solutions in OIC drugs is sizable
and expanding quickly, particularly in developed regions.
The key factors igniting the
growth of the opioid-induced constipation (OIC) treatment business sector are
the rising base of illicit drug users and the delayed use of opioids in the
treatment of chronic pain. Additionally, greater awareness of the benefits of
using non-purgative medications to treat opioid-induced constipation among
patients and physicians would hasten the growth of the OIC treatment market. The
main barriers to the market for treating opioid-induced constipation include
patients' lack of knowledge about the condition, their lack of interest in new
treatments, the high costs of novel medications, and the unfavourable
reimbursement policies of medical coverage organizations.
Comments
Post a Comment